We also observed a lower Treg CTLA-4+ frequency in Pool CoV-2-stimulated PBMC from Mild Recovered volunteers who had experienced fatigue, anosmia, and ageusia than in those who had not developed these symptoms (Figure 4B). This evidence concerns the gene CTLA4 and Anosmia.